Diet and heart health: Moderate wine drinking strengthens the cardioprotective effects of fish consumption

Current Pharmaceutical Biotechnology

Volumn 11, Issue 8, 2010, Pages 911-921

  de Leiris, J ^a   Besse, S ^b   Boucher, F ^a  

^a LABORATOIRE TIMC IMAG   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Coronary heart disease; Heart health; Marine omega 3 fatty acid; Mediterranean diet; Wine

Indexed keywords

ALCOHOL; ANTHOCYANIN; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FISH OIL; FLAVONOID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHENOL; PHYTOALEXIN; PLACEBO; POLYPHENOL; PROCYANIDIN; RESVERATROL; SUNFLOWER OIL; CARDIOTONIC AGENT; PHENOL DERIVATIVE; POLYPHENOLS;

ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; FISH; FOOD INTAKE; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART PROTECTION; HUMAN; MEDITERRANEAN DIET; NONHUMAN; PALEOLITHIC; PREVENTIVE MEDICINE; REVIEW; WINE; ANIMAL; BLOOD PRESSURE; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; HEALTH; HEART; MALE; MORTALITY; PHYSIOLOGY; STROKE;

ALCOHOL DRINKING; ANIMALS; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CORONARY DISEASE; DIET, MEDITERRANEAN; FATTY ACIDS, OMEGA-3; FEMALE; FISHES; FLAVONOIDS; HEALTH; HEART; HUMANS; MALE; PHENOLS; STROKE; WINE;

EID: 79957937076     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110793262024     Document Type: Review

References (83)

1. Whithmer, J.T.; Idell-Wenger, J.A.; Rovetto, M.J.; Neely, J.R. Control of fatty acid metabolism in ischemic and hypoxic hearts. J. Biol. Chem., 1978, 253(12), 4305-4309.
2. De Leiris, J.; Lubbe, W.F.; Opie, L.H. Effects of free fatty acids and glucose on enzyme release in experimental myocardial infarction. Nature (London). 1975, 253(5497), 746-747.
3. Opie, L.H. Myocardial metabolism and heart disease. Jpn. Circ. J. 1978, 42(11), 1223-1247.
4. Neely, J.R.; Feuvray, D. Metabolic products and myocardial ischemia. Am. J. Pathol., 1981, 102(2), 282-291.
5. O'Keefe, J.H. Jr.; Cordain, L. Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21th-century hunter-gatherer. Mayo Clin. Proc., 2004, 79(1), 101-108.
6. Di Guiseppe, R.; De Lorgeril, M.; Salen, P.; Laporte, F.; Di Castelnuovo, A.; Krogh, V.; Siani, A.; Arnout, J.; Cappuccio, F.P.; Van Dongen, M.; Donati, M.B.; De Gaetano, G.; Iacoviello, L. Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 european populations. European collaborative group IMMIDIET project. Am. J. Clin. Nutr. 2009, 89(1), 354-362.
7. Sinclair, H.M. Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet. 1956, 270(6919), 381-383.
8. Bjerregaard, P.; Dyerberg, J. Mortality form ischemic heart disease and cerebrovascular disease in Greenland. Int. J. Epidemiol., 1988, 17(3), 514-519.
9. Bjerregaard, P.; Mulvad, G.; Pedersen, H.S. Cardiovascular risk factors in Inuit in Greenland. Int. J. Epidemiol. 1997, 26(6), 1182-1190.
10. Dyerberg, J.; Bang, H.O.; Hjome N. Fatty acid composition of the plasma lipid in Greenland Eskimos. Am. J. Clin. Nutr. 1975, 28(9), 958-966.
11. Bang, H.O.; Dyerberg, J.; Sinclair, H.M. The composition of the Eskimo food in north western Greenland. Am. J. Clin. Nutr. 1980, 33(12), 2657-2661.
12. Breslow, J.L. n-3 fatty acids and cardiovascular disease. Am. J. Clin. Nutr. 2006, 83(6), 1477S-1482S.
13. Lee, J.H.; O'Keefe, J.H.; Lavie, C.J.; Marchioli, R.; Harris, W.S. Omega-3 fatty acid for cardioprotection. Mayo Clin. Proc. 2008, 83(3), 324-332.
14. Sun, Q.; Ma, J.; Campos, H.; Rexrode, J.M.; Albert, C.M.; Mozaffarian, D.; Hu, F.B. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am. J. Clin. Nutr., 2008, 88(1), 216-223.
15. Burdge, G.C.; Wootton, S.A. Conversion of alpha-linolenic acid to eicosapentanenoic, docosapentanenoic and docosahexaenoic acids in young women. Br. J. Nutr., 2002, 88(4), 411-420.
16. Schmidt, E.B.; Skou, H.E.; Christensen, J.H.; Dyerberg, J. n-3 fatty acids from fish and coronary artery disease: implications for public health. Public Health Nutr. 2000, 3(1), 91-98.
17. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999, 354(9177), 447-455.
18. Burr, M.L.; Fehily, A.M.; Gilbert, J.F.; Rogers, S.; Holliday, R.M.; Swettnam, P.M.; Elwood, P.C.; Deadman, N.M. Effect of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989, 2(8666), 757-761.
19. Raitt, M.H.; Connor, W.E.; Morris, C.; Kron, J.; Halperin, B.; Chugh, S.S.; McClelland, J.; Cool, J.; MacMurdy, K.; Swenson, R.; Connor, SL.; Gerhard, G.; Kraemer, D.F.; Oseran, D.; Marchant, C.; Calhoun, D.; Shnider, R.; McAnulty, J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. JAMA, 2005, 293(23), 2884-2891.
20. Leon, H.; Shibata, M.C.; Sivakumaran, S.; Dorgan, M.; Chatterley, T.; Tsuyuki, R.T. Effect of fish oil on arrhythmias and mortality: systematic review. Br. Med. J., 2008, 337. a2931.
21. Leaf, A.; Xiao, Y.F.; Kang, J.X.; Billman, G.E. Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J. Membr. Biol., 2005, 206(2), 129-139.
22. +channel. Proc. Natl. Acad. Sci. USA. 1998, 95(5), 2680-2685.
23. 2+currents by polyunsaturated fatty acids in adult and neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. USA. 1997, 94(8), 4182-4187.
24. Simopoulos, A.P. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr., 1999, 70(3suppl), 560S-598S
25. Simopoulos, A.P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 1991, 54(3), 438-463.
26. Bayon, Y.; Croset, M.; Daveloose, D.; Guerbette, F.; Chirouze, V.; Viret, J.; Kader, J.C.; Lagarde, M. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. J. Lipid Res., 1995, 36(1), 47-56.
27. Thies, F.; Garry, J.M.; Yaqoob, P.; Rerkasem, K.; Williams, J.; Shearman, C.P.; Gallagher, P.J.; Calder, P.C.; Grimble, R.F. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003, 361(9356), 477-485.
28. Skerrett, P.J.; Hennekens, C.H. Consumption of fish and fish oils and decreased risk of stroke. Prev. Cardiol., 2003, 6(1), 38-41.
29. Iso, H.; Rexrode, K.M.; Stampfer, M.J.; Manson, J.E.; Colditz, G.A.; Speizer, F.E.; Hennekens, C.H.; Willett, W.C. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA, 2001, 285(3), 304-312.
30. Ueshima, H.; Stamler, J.; Elliott, P.; Chan, Q.; Brown, I.J.; Carnethon, M.R.; Daviglus, M.L.; He, K.; Moag-Stahlberg, A.; Rodriguez, B.L.; Steffen, L.M.; Van Horn, L.; Yarnell, J.; Zhou, B. Food omega-3 fatty acid intake of individuals (total, linolenic acid, longchain) and their blood pressure INTERMAP study. Hypertension. 2007, 50(2),313-319.
31. Geleijnse, J.M.; Giltay, E.J.; Grobbee, D.E.; Donders, A.R.; Kok, F.J. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens., 2002, 20(8), 1493-1499.
32. Rasmussen, B.M.; Vessby, B.; Uusitupa, M.; Berglund, L.; Pedersen, E.; Riccardi, G.; Rivellese, A.A.; Tapsell, L.; Hermansen, K. for the KANWU Study Group. Effects of dietary saturated, monounsaturated and n-3 fatty acids on blood pressure in healthy subjects. Am. J. Clin. Nutr., 2006, 83(2), 221-226.
33. Shimokawa, H.; Vanhoutte, P.M. Dietary omega 3 fatty acids and endothelium-dependent relaxations in porcine coronary arteries. Am. J. Physiol., 1989, 256(4), H968-H973.
34. Yin, K.; Chu, Z.M.; Beilin, L.J. Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oils. Brit. J. Pharmacol., 1991, 102(4), 991-997.
35. Chu, Z.M.; Yin, K.; Beilin, L.J. Fish oil feeding selectively attenuates contractile responses to noradrenaline and electrical stimulation in the perfused mesenteric resistance vessels of spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol., 1992, 19(3), 177-181.
36. McVeigh, G.E.; Brennan, G.M.; Cohn, J.N.; Finkelstein, S.M.; Hayes, R.J.; Johnston, G.D. Fish oil improves arterial compliance in noninsulindependent diabetes mellitus. Arterioscler. Thromb., 1994, 14(9), 1425-1429.
37. Stamler, J.; Rose, G.; Stamler, R.; Elliott, P.;Dyer, A.; Marmot, M. INTERSALT study findings: Public health and medical care implications. Hypertension. 1989, 14(5), 570-577.
38. Saito, M.; Nakatsugawa, K. Increased susceptibility of liver to lipid peroxidation after ingestion of a high fish oil diet. Int. J. Vitam. Nutr. Res., 1994, 64(2), 144-151.
39. Basso, M.M.; Eynard, A.R.; Valentich, M.A. Dietary lipids modulate fatty acid composition, gamma glutamyltranspeptidase and lipid peroxidation levels of epididymis tissue in mice. Anim. Reprod. Sci., 2006, 92(3-4), 364-372.
40. Kris-Etherton, P.M.; Harris, W.S.; Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 2002, 106(21), 2747-2757.
41. St Leger, A.S.; Cochrane, A. L; Moore, F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1979, 1(8124), 1017-1020.
42. Renaud, S.; De Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992, 339(8808), 1523-1526.
43. Providência, R. Cardiovascular protection from alcoholic drinks: scientific basis of the French Paradox. Rev. Port. Cardiol., 2006, 25(11), 1043-1058.
44. Albert, C.M.; Manson, J.E.; Cook, N.R.; Ajani, U.A.; Gaziano, J.M.; Hennekens, C.H. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation. 1999, 100(9), 944-950.
45. Mukamal, K.J.; Conigrave, K.M.; Mittleman, M.A.; Camargo, C.A. Jr.; Stampfer, M.J.; Willett, W.C.; Rimm, E.B. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N. Engl. J. Med., 2003, 348(2), 109-118.
46. De Lorgeril, M.; Salen, P.; Martin, J.L.; Boucher, F.; Paillard, F., De Leiris, J. Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation. 2002, 106(12), 1465-1469.
47. Corder R. The Wine Diet. Sphere Publishers: London, 2007.
48. Fuchs, F.D.; Chambless, L.E.; Folsom, A.R.; Eigenbrodt, M.L.; Duncan, B.B.; Gilbert, A.; Szklo, M. Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks. Am. J. Epidemiol., 2004, 160(5), 466-474.
49. Klatsky, A.L.; Friedman, G.D.; Armstrong, M.A.; Kipp, H. Wine, liquor, beer, and mortality. Am. J. Epid., 2003, 158(6), 585-595.
50. Grønbaek, M.; Deis, A.; Sørensen, T.I.; Becker, U.; Schnohr, P.; Jensen, G. Mortality associated with moderate intakes of wine, beer or spirits. Br. Med. J. 1995, 310(6988), 1165-1169.
51. Grønbaek, M.; Becker, U.; Johansen, D.; Gottschau, A.; Schnohr, P.; Hein, H.O.; Jensen, G.; Sørensen, T.I. Type of alcohol consumed and mortality from all causes, coronary disease, and cancer. Ann. Intern. Med., 2000, 133(6), 411-419.
52. Renaud, S.C.; Gueguen, R.; Siest, G.; Salamon, R. Wine, beer, and mortality in middle-aged men from eastern France. Arch. Intern. Med., 1999, 159(16), 1865-1870.
53. Muntwyler, J.; Hennekens, C.H.; Buring, J.E.; Gaziano, J.M. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet. 1998, 352(9144), 1882-1885.
54. Shaper, A.G.; Wannamethee, S.G. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease. Heart. 2000, 83(4), 394-399.
55. Mukamal, K.J.; Maclure, M.; Muller, J.E.; Sherwood, J.B.; Mittleman, M.A. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA, 2001, 285(15), 1965-1970.
56. Van de Wiel, A.; Van Golde, P.H.; Hart, H.C. Blessings of the grape. Eur. J. Intern. Med. 2001, 12(6), 484-489.
57. Bertelli, A.A. Wine, research and cardiovascular disease: instructions for use. Atherosclerosis. 2007, 195(2), 242-247.
58. Bertelli, A.A.; Migliori, M.; Panichi, V.; Longoni, B.; Origlia, N.; Ferretti, A.; Cuttano, M.G.; Giovannini, L. Oxidative stress and inflammatory reaction modulation by white wine. Ann. N. Y. Acad. Sci., 2002, 957. 295-301.
59. Lucas, D.L.; Brown, R.A.; Wassef, M.; Giles, T.D. Alcohol and the cardiovascular system. J. Am. Coll. Cardiol., 2005, 45(12), 1916-1924.
60. Rakotovao, A.; Berthonneche, C.; Guiraud, A.; De Lorgeril, M.; Salen, P.; De Leiris, J.; Boucher F. Ethanol, wine, and experimental cardioprotection in ischemia-reperfusion: role of the prooxidant/ antioxidant balance. Antioxid. Redox Signal., 2004, 6(2), 431-438.
61. Guiraud, A.; De Lorgeril, M.; Boucher, F.; Berthonneche, C.; Rakotovao, A.; De Leiris, J. Cardioprotective effect of chronic low dose ethanol drinking. Insights into the concept of ethanol preconditioning. J. Mol. Cell. Cardiol., 2004, 36(4), 561-566.
62. Sparagna, G.C.; Jones, C.E.; Hickson-Bick, D.L. Attenuation of fatty acid-induced apoptosis by low-dose alcohol in neonatal rat cardiomyocytes. Am. J. Physiol. 2004, 287(5), H2209-H2215.
63. Inagaki, K.; Mochly-Rosen, D. δ-PKC-mediated activation of δ-PKC in ethanol-induced cardiac protection from ischemia. J. Mol. Cell. Cardiol., 2005, 39(2), 203-211.
64. Nicolli, G.; Altamura, L.; Fabretti, A.; Lanza, G.A.; Biasucci, L.M.; Rebuzzi, A.G.; Leone, A.M.; Porto, I.; Burzotta, F.; Trani, C.; Crea, F. Ethanol abolishes ischemic preconditioning in humans. J. Am. Coll. Cardiol. 2008, 51(3), 271-275.
65. Su, C.Y.; Chong, K.Y.; Owen, O.E.; Dillmann, W.H.; Chang, C.; Lai, C.C. Constitutive and inducible HSP70s are involved in oxidative resistance evoked by heat shock or ethanol. J. Mol. Cell. Cardiol., 1998, 30(3), 587-598.
66. Sato, M.; Maulik, N.; Das, D.K. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann. N. Y. Acad. Sci., 2002, 957. 122-135.
67. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1), 230S-242S.
68. Estruch, R.; Sacanella, E.; Badia, E.; Antunez, E.; Nicolas, J.M.; Fernandez-Sola, J.; Rotilio, D.; De Gaetano, G.; Rubin, E.; Urbano-Marquez, A. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: A prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis. 2004, 175(1), 117-123.
69. Toufektsian, M.C.; De Lorgeril, M.; Nagy, N.; Salen, P.; Donati, M.B.; Giordano, L.; Mock, H.P.; Peterek, S.; Matros, A.; Petroni, K.; Pilu, R.; Rotilio, D.; Tonelli, C.; De Leiris, J.; Boucher, F.; Martin, C. Protection against myocardial infarction after long-term chronic dietary intake of plantderived anthocyanins protects the rat heart against regional ischemia-reperfusion injury. J. Nutr. 2008, 138(4), 747-752.
70. Ferrali, M.; Signorini, C.; Caciotti, B.; Sugherini, L.; Ciccoli, L.; Giachetti, D.; Comporti, M. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett., 1997, 416(2), 123-129.
71. Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: the in-vivo evidence. Nat. Rev. Drug Discov., 2006, 5(6), 493-506.
72. Szabo, M.E.; Gallyas, E.; Bak, I.; Rakotovao, A.; Boucher, F.; De Leiris, J.; Nagy, N.; Varga, E.; Tosaki, A. Heme oxygenase-1-related carbon monoxide and flavonoids in ischemic/reperfused rat retina. Invest. Ophtalmol. Vis. Sci., 2004, 45(10), 3727-3732.
73. Bak, I.; Lekli, I.; Juhasz, B.; Nagy, N.; Varga, E.; Varadi, J.; Gesztelyi, R.; Szabo, G.; Szendrei, L.; Bacskay, I.; Vecsernyes, M.; Antal, M.; Fesus, L.; Boucher, F.; De Leiris, J.; Tosaki, A. Cardioprotective mechanisms of Prunus cerasus (sour cherry) seed extract against ischemia-reperfusion-induced damage in isolated rat hearts. Am. J. Physiol. 2006, 291(3), H1329-H1336.
74. Das, D.K.; Maulik, N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv., 2006, 6(1), 37-47.
75. Thirunavukkarasu, M.; Penumathsa, S.V.; Koneru, S.; Juhasz, B.; Zhan, L.; Otani, H.; Bagchi, D.; Das, D.K.; Maulik, N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic. Biol. Med., 2007, 43(5), 720-729.
76. Das, S.; Tosaki, A.; Bagchi, D.; Maulik, N.; Das D.K. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen-and stress-activated protein kinase 1/cAMP response element-binding protein signaling. J. Pharmacol. Exp. Ther., 2006, 317. 980-988.
77. Tauchert, M. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable NYHA class-III heart failure. Am. Heart J., 2002, 143(5), 910-915.
78. Chatterjee, S.S.; Koch, E.; Jaggy, H.; Krzeminski, T. In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms. Arzneimittelforschung. 1997, 47(7), 821-825.
79. Al-Makdessi, A.; Sweidan, H.; Jacob, R. Effect of oligomer procyanidins on reperfusion arrhythmias and lactate dehydrogenase release in the isolated rat heart. Arzneimittelforschung. 2006, 56(5), 317-321.
80. Ferrières, J. The French paradox: lessons for other countries. Heart. 2004, 90(1), 107-111.
81. Mukamal, K.J.; Maclure, M.; Muller, J.E.; Mittleman, M.A. Binge drinking and mortality after acute myocardial infarction. Circulation. 2005, 112(25), 3839-3845.
82. De Lorgeril, M.; Salen, P.; Martin, J.L.; Boucher, F.; De Leiris, J. Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease. Am. Heart J., 2008, 155(1), 175-181.
83. Guiraud, A.; De Lorgeril, M.; Zeghichi, S.; Laporte, F.; Salen, P.; Saks, V.; Berraud, N.; Boucher, F.; De Leiris, J. Interactions of ethanol drinking with n-3 fatty acids in rats: potential consequences for the cardiovascular system. Br. J. Nutr., 2008, 100(6), 1237-1244.